The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 4×

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 2×

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849

APP Processing and Synaptic Function

Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644

Purification and cloning of amyloid precursor protein β-secretase from human brain

Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612

Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study

Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588

Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438

Tor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast

Noda, T., & Ohsumi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3963 · Cited by 1,303

Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo

Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265

Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid β production

Zoltowska, K. M., Maesako, M., Lushnikova, I., Takeda, S., Keller, L. J., Skibo, G., Hyman, B. T., & Berezovska, O. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0159-y · Cited by 36

Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation

Sobue, A., Komine, O., Endo, F., Kakimi, C., Miyoshi, Y., Kawade, N., Watanabe, S., Saito, Y., Murayama, S., Saido, T. C., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07249-6 · Cited by 41

Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection

Taliyan, R., Chandran, S. K., & Kakoty, V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716101411 · Cited by 35

Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta

Kuzuya, A., Zoltowska, K. M., Post, K. L., Arimon, M., Li, X., Svirsky, S. E., Maesako, M., Muzikansky, A., Gautam, V., Kovacs, D. M., et al. (2016) · BMC Biology · doi:10.1186/s12915-016-0248-3 · Cited by 35

BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice

Kim, W., Ma, L., Lomoio, S., Willen, R., Lombardo, S., Dong, J., Haydon, P. G., & Tesco, G. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0239-7 · Cited by 32

Implications for BACE1 Inhibitor Clinical Trials: Adult Conditional BACE1 Knockout Mice Exhibit Axonal Organization Defects in the Hippocampus

Vassar, R. J. (2019) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2019.3 · Cited by 32

Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer’s Disease

Ettcheto, M., Abad, S., Petrov, D., Pedrós, I., Busquets, O., Sánchez‐López, E., Casadesús, G., Beas‐Zárate, C., Carro, E., Auladell, C., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0690-4 · Cited by 28

BACE1 partial deletion induces synaptic plasticity deficit in adult mice

Lombardo, S., Chiacchiaretta, M., Tarr, A. J., Kim, W., Cao, T., Sigal, G., Rosahl, T. W., Xia, W., Haydon, P. G., Kennedy, M. E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56329-7 · Cited by 30

KIF1A mediates axonal transport of BACE1 and identification of independently moving cargoes in living SCG neurons

Hung, C., & Coleman, M. P. (2016) · Traffic · doi:10.1111/tra.12428 · Cited by 30

Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1

Sun, M., & Zhang, H. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.024 · Cited by 30

The Potential Mechanism and the Role of Antioxidants in Mitigating Oxidative Stress in Alzheimer’s Disease

Naik, R. A., Mir, M. N., Malik, I. A., Bhardwaj, R., Alshabrmi, F. M., Mahmoud, M. A., Alhomrani, M., Alamri, A. S., Alsanie, W. F., Hjazi, A. M., et al. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25551 · Cited by 29

Beneficial Effects of the β-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer’s Transgenic Mice Lessen During Disease Progression

Devi, L., Tang, J., & Ohno, M. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666141218125042 · Cited by 28

Post-translational regulation of the β-secretase BACE1

Araki, W. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.009 · Cited by 26

Complementary roles of the neuron‐enriched endosomal proteins NEEP21 and calcyon in neuronal vesicle trafficking

Muthusamy, N., Chen, Y., Yin, D., Mei, L., & Bergson, C. M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12989 · Cited by 26

Neurogranin and BACE1 in CSF as Potential Biomarkers Differentiating Depression with Cognitive Deficits from Early Alzheimer’s Disease: A Pilot Study

Schipke, C. G., Vos, A. D., Fuentes, M., Jacobs, D., Vanmechelen, E., & Peters, O. (2018) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000489847 · Cited by 27

Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target

Syeda, T., & Cannon, J. R. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22694 · Cited by 30

Effects of altered RTN3 expression on BACE1 activity and Alzheimer’s neuritic plaques

Sharoar, M. G., & Yan, R. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0054 · Cited by 28

Effects of BACE1 Haploinsufficiency on APP Processing and Aβ Concentrations in Male and Female 5XFAD Alzheimer Mice at Different Disease Stages

Devi, L., & Ohno, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.037 · Cited by 28

LRP1 Downregulates the Alzheimer’s β-Secretase BACE1 by Modulating Its Intraneuronal Trafficking

Tanokashira, D., Motoki, K., Minegishi, S., Hosaka, A., Mamada, N., Tamaoka, A., Okada, T., Lakshmana, M. K., & Araki, W. (2015) · eNeuro · doi:10.1523/eneuro.0006-15.2015 · Cited by 25

Olfactory experience modulates immature neuron development in postnatal and adult guinea pig piriform cortex

He, X., Zhang, X.-M., Wu, J., Fu, J. X., Mou, L.-P., Lu, D., Cai, Y., Luo, X.-G., Pan, A., & Yan, X.-X. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.056 · Cited by 25

Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels

Deng, Q., Dong, X., Wu, H., Wang, W., Wang, Z., Zhu, J.-W., Liu, C., Jia, W., Zhang, Y., Schachner, M., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.164 · Cited by 25

Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer’s disease

Yeganeh, P. N., Kwak, S. S., Jorfi, M., Koler, K., Kalatturu, T., von Maydell, D. K., Liu, Z., Guo, K., Choi, Y., Park, J., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.10.029 · Cited by 24

Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives

Sun, B., Chen, Y., Fan, D., Zhu, C., Zeng, F., & Wang, Y. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1810-y · Cited by 27

Distinct Rab7-related Endosomal–Autophagic–Lysosomal Dysregulation Observed in Cortex and Hippocampus in APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease

Ba, L., Chen, X., Chen, Y., Qing, N., Li, Z., Ding, F., & Zhang, M. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.220311 · Cited by 23

Gga3 deletion and a GGA3 rare variant associated with late onset Alzheimer’s disease trigger BACE1 accumulation in axonal swellings

Lomoio, S., Willen, R., Kim, W., Ho, K., Robinson, E. K., Prokopenko, D., Kennedy, M. E., Tanzi, R. E., & Tesco, G. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba1871 · Cited by 23

Palmitic Acid-Induced NAD+ Depletion is Associated with the Reduced Function of SIRT1 and Increased Expression of BACE1 in Hippocampal Neurons

Flores‐León, M., Pérez‐Domínguez, M., González‐Barrios, R., & Arias, C. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02810-8 · Cited by 24

Proximity ligation assay reveals both pre- and postsynaptic localization of the APP-processing enzymes ADAM10 and BACE1 in rat and human adult brain

Lundgren, J. L., Vandermeulen, L., Matton, A., Ahmed, S., Winblad, B. G., Luca, M. D., Tjernberg, L. O., Marcello, E. E., & Frykman, S. (2020) · BMC Neuroscience · doi:10.1186/s12868-020-0554-0 · Cited by 23

Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies

Kotarba, S., Kozłowska, M., Scios, M., Saramowicz, K., Barczuk, J., Granek, Z., Siwecka, N., Wiese, W., Golberg, M., Galita, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910797 · Cited by 24

Casein Kinase 2 dependent phosphorylation of eIF4B regulates BACE1 expression in Alzheimer’s disease

Bettegazzi, B., Monasor, L. S., Bellani, S., Codazzi, F., Restelli, L. M., Colombo, A. V., Deigendesch, N., Frank, S., Saito, T., Saido, T. C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04062-3 · Cited by 20

Design, synthesis, and biological evaluation of novel capsaicin-tacrine hybrids as multi-target agents for the treatment of Alzheimer's disease

Long, J., Qin, F., Luo, J., Zhong, G., Huang, S., Jing, L., Yi, T., Liu, J., & Jiang, N. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.107026 · Cited by 21

SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1

Kurkinen, K. M. A., Marttinen, M., Turner, L. J., Natunen, T., Mäkinen, P. M., Haapalinna, F., Sarajärvi, T., Gabbouj, S., Kurki, M., Paananen, J., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.185215 · Cited by 21

The Association of Amyloid-β Protein Precursor With α- and β-Secretases in Mouse Cerebral Cortex Synapses Is Altered in Early Alzheimer’s Disease

Pliássova, A., Lopes, J. P., Lemos, C., Oliveira, C. R., Cunha, R. A., & Agostinho, P. M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9491-9 · Cited by 21

Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model

Pan, T.-T., Sun, Y., Shi, Y.-F., Zhao, M., Khan, N. U., Chen, H., Ji, W., Li, J., Han, L., & Ma, Q. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01840-5 · Cited by 19

ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer’s disease

Ramsden, C. E., Zamora, D., Horowitz, M. S., Jahanipour, J., Calzada, E., Li, X., Keyes, G. S., Murray, H. C., Curtis, M. A., Faull, R. L. M., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01693-9 · Cited by 21

BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains

Čaušević, M., Dominko, K., Malnar, M., Vidatic, L., Čermak, S., Pigoni, M., Kuhn, P., Colombo, A. V., Havas, D., Flunkert, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200344 · Cited by 20

Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer’s Disease in Humans

Ramsden, C. E., Keyes, G. S., Calzada, E., Horowitz, M. S., Zamora, D., Jahanipour, J., Sedlock, A., Indig, F. E., Moaddel, R., Kapogiannis, D., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220071 · Cited by 19

Demyelination-derived lysophosphatidylserine promotes microglial dysfunction and neuropathology in a mouse model of Alzheimer’s disease

Zhou, Y., Huang, Z., Lin, B., Ma, M., Hao, Y., Liu, J., Xu, W., Huang, G., Mo, W., Wang, X., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01235-w · Cited by 19

Alzheimer’s disease basics: we all should know

Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19

Simultaneous imaging of redox states in dystrophic neurites and microglia at Aβ plaques indicate lysosome accumulation not microglia correlate with increased oxidative stress

Wendt, S., Johnson, S., Weilinger, N. L., Groten, C., Sorrentino, S., Frew, J., Yang, L., Choi, H. B., Nygaard, H. B., & MacVicar, B. A. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102448 · Cited by 20

Study of Exosomes Shed New Light on Physiology of Amyloidogenesis

van Niel, G. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0357-0 · Cited by 20

Lysosome Function and Dysfunction in Hereditary Spastic Paraplegias

Edmison, D., Wang, L., & Gowrishankar, S. (2021) · Brain Sciences · doi:10.3390/brainsci11020152 · Cited by 18

Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice

Cuddy, L. K., Alia, A. O., Salvo, M. A., Chandra, S., Grammatopoulos, T. N., Justman, C. J., Lansbury, P. T., Mazzulli, J. R., & Vassar, R. J. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00561-9 · Cited by 17

β-Secretase BACE1 Promotes Surface Expression and Function of Kv3.4 at Hippocampal Mossy Fiber Synapses

Hartmann, S., Zheng, F., Kyncl, M. C., Karch, S., Voelkl, K., Zott, B., D’Avanzo, C., Lomoio, S., Tesco, G., Kim, D. Y., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2643-17.2018 · Cited by 17

Experimental approaches for altering the expression of Abeta‐degrading enzymes

Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 18

α-secretase ADAM10 physically interacts with β-secretase BACE1 in neurons and regulates CHL1 proteolysis

Wang, X., Wang, C., & Pei, G. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy001 · Cited by 17

Correction of microtubule defects within Aβ plaque‐associated dystrophic axons results in lowered Aβ release and plaque deposition

Yao, Y., Nzou, G., Alle, T., Tsering, W., Maimaiti, S., Trojanowski, J. Q., Lee, V. M. ‐., Ballatore, C., & Brunden, K. R. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12144 · Cited by 17

High Fat Diet Mediates Amyloid-β Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice

Bao, J., Liang, Z., Gong, X., Yu, J. H., Xiao, Y., Liu, W. D., Wang, X., Wang, J., & Shu, X. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215299 · Cited by 16

Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer’s disease model mice

Sadleir, K. R., Gómez, K., Edwards, A. E., Patel, A. J., Ley, M. L., Khatri, A. W., Guo, J., Mahesh, S., Watkins, E. A., Popović, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02888-1 · Cited by 18

Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer's disease

Ashwini, P., Bodhankar, S. L., Muthal, A., Kumar, D., Pawar, A., & Kulkarni, R. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.11.016 · Cited by 19

The BACE1-Specific DNA Aptamer A1 Rescues Amyloid-β Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease

Liang, Z., Peng, Y., Chen, Y., Long, L.-L., Luo, H.-J., Chen, Y., Liang, Y., Tian, Y.-H., Li, S.-J., Shi, Y., et al. (2019) · Nucleic Acid Therapeutics · doi:10.1089/nat.2019.0812 · Cited by 14

Disruptions in axonal lysosome transport and its contribution to neurological disease

Paumier, J., & Gowrishankar, S. (2024) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2024.102382 · Cited by 16

Inhibiting 5-hydroxytryptamine receptor 3 alleviates pathological changes of a mouse model of Alzheimer’s disease

Liu, L.-F., Liu, Y.-T., Wu, D.-D., Cheng, J., Li, N., Zheng, Y.-N., Huang, L., & Yuan, Q.-L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.366492 · Cited by 14

Synapsin 1 promotes Aβ generation via BACE1 modulation

Maesako, M., Zoltowska, K. M., & Berezovska, O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226368 · Cited by 14

BACE1 and cholinesterase inhibitory activities of compounds from Cajanus cajan and Citrus reticulata: an in silico study

Adewole, K. E., & Ishola, A. A. (2021) · In Silico Pharmacology · doi:10.1007/s40203-020-00067-6 · Cited by 14

BACE1 Translation: At the Crossroads Between Alzheimer’s Disease Neurodegeneration and Memory Consolidation

Guix, F. X., Sartório, C. L., & ILL‐Raga, G. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-180089 · Cited by 13

Cerebrospinal fluid levels of synaptic and neuronal integrity correlate with gray matter volume and amyloid load in the precuneus of cognitively intact older adults

Schaeverbeke, J. M., Gille, B., Adamczuk, K., Vanderstichele, H., Chassaing, E., Bruffaerts, R., Neyens, V., Stoops, E., Tournoy, J., Vandenberghe, R. R., et al. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14680 · Cited by 13

Lack of β-amyloid cleaving enzyme-1 (BACE1) impairs long-term synaptic plasticity but enhances granule cell excitability and oscillatory activity in the dentate gyrus in vivo

Vnencak, M., Schölvinck, M. L., Schwarzacher, S. W., Deller, T., Willem, M., & Jedlička, P. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01836-6 · Cited by 13

pHluorin-BACE1-mCherry Acts as a Reporter for the Intracellular Distribution of Active BACE1 In Vitro and In Vivo

Zhao, L., Zhao, Y., Tang, F., Xiong, L., Su, C., Mei, L., Zhu, X., & Xiong, W. (2019) · Cells · doi:10.3390/cells8050474 · Cited by 13

Bacopa monnieri phytochemicals as promising BACE1 inhibitors for Alzheimer’s disease therapy

Sangeet, S., & Khan, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-92644-y · Cited by 13

Significance of transcytosis in Alzheimer's disease: BACE1 takes the scenic route to axons

Buggia-Prévot, V., & Thinakaran, G. (2015) · BioEssays · doi:10.1002/bies.201500019 · Cited by 14

Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse Model

Njavro, J. R., Vukicevic, M., Fiorini, E., Dinkel, L., Müller, S. A., Berghofer, A., Bordier, C., Kozlov, S. O., Halle, A., Buschmann, K., et al. (2022) · Cells · doi:10.3390/cells12010079 · Cited by 13

BACE1 as an early biomarker and its relevance to risk factors for Alzheimer’s disease

Ohno, M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111475 · Cited by 12

Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1

Miyamoto, M., Kuzuya, A., Noda, Y., Ueda, S., Asada‐Utsugi, M., Ito, S., Fukusumi, Y., Kawachi, H., Takahashi, R., & Kinoshita, A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200071 · Cited by 11

Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis

Sadleir, K. R., Popović, J., Khatri, A. W., & Vassar, R. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263332 · Cited by 11

Ex vivo analysis platforms for monitoring amyloid precursor protein cleavage

Kamikubo, Y., Jin, H., Zhou, Y., Niisato, K., Hashimoto, Y., Takasugi, N., & Sakurai, T. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1068990 · Cited by 11

Inhibitory effects of β-asarone on lncRNA BACE1-mediated induction of autophagy in a model of Alzheimer’s disease

Wang, Z., Zhou, J., Zhang, B., Xu, Z., Wang, N., Sun, Q., & Wang, N. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.114896 · Cited by 10

BIN1K358R suppresses glial response to plaques in mouse model of Alzheimer's disease

Garcia‐Agudo, L. F., Shi, Z., Smith, I. F., Kramár, E. A., Tran, K., Kawauchi, S., Wang, S., Collins, S., Walker, A., Shi, K., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13767 · Cited by 12

Serum Glycoproteomics and Identification of Potential Mechanisms Underlying Alzheimer’s Disease

Kerdsaeng, N., Roytrakul, S., Chanprasertyothin, S., Charernwat, P., Chansirikarnjana, S., Sritara, P., & Sirivarasai, J. (2021) · Behavioural Neurology · doi:10.1155/2021/1434076 · Cited by 10

In Vivo Reductionist Approach Identifies miR-15a Protecting Mice From Obesity

Murgia, N., Ma, Y., Najam, S. S., Liu, Y., Przybyś, J., Guo, C., Konopka, W., & Vinnikov, I. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867929 · Cited by 11

Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease

Bergkvist, L., Du, Z., Elovsson, G., Appelqvist, H., Itzhaki, L. S., Kumita, J. R., Kågedal, K., & Brorsson, A. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12773 · Cited by 10

Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets

Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12

Genetic architecture of hippocampus subfields volumes in Alzheimer’s disease

Cai, J., Xiong, W., Wang, X., Tan, H., & Database, T. A. D. N. I. (. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14110 · Cited by 9

Regulation of BACE1 expression after injury is linked to the p75 neurotrophin receptor

Saadipour, K., Tiberi, A., Lombardo, S., Grajales, E., Montroull, L. E., Manucat-Tan, N. B., LaFrancois, J. J., Cammer, M., Mathews, P. M., Scharfman, H. E., et al. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103395 · Cited by 9

Alleviation of Neurological Disorders by Targeting Neurodegenerative-Associated Enzymes: Natural and Synthetic Molecules

Singh, A. A., Khan, F., & Song, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104707 · Cited by 10

Cysteine string protein alpha accumulates with early pre-synaptic dysfunction in Alzheimer’s disease

Rupawala, H., Shah, K., Davies, C., Rose, J. L., Colom‐Cadena, M., Peng, X., Granat, L., Aljuhani, M., Mizuno, K., Troakes, C., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac192 · Cited by 8

Metabolic response of microglia to amyloid deposition during Alzheimer’s disease progression in a mouse modelPreprint

Marino, K. M., Squirrell, J. M., Chacko, J. V., Watters, J. J., Eliceiri, K. W., & Ulland, T. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.12.540407 · Cited by 8

Safety concerns associated with BACE1 inhibitors – past, present, and future

Naidu, A., Silverglate, B., Silverglate, M., & Grossberg, G. T. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2467811 · Cited by 7

High-Phytate Diets Increase Amyloid β Deposition and Apoptotic Neuronal Cell Death in a Rat Model

Kim, H., Jung, Y.-S., Jung, Y., Kim, O., & Oh, B. (2021) · Nutrients · doi:10.3390/nu13124370 · Cited by 7

Pathological Links between Traumatic Brain Injury and Dementia: Australian Pre-Clinical Research

Collins, J. M., Woodhouse, A., Bye, N., Vickers, J. C., King, A. E., & Ziebell, J. M. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6906 · Cited by 8

Neuroprotective Effects of a Multi-Herbal Extract on Axonal and Synaptic Disruption in Vitro and Cognitive Impairment in Vivo

Lin, N., Goh, A., Lin, S., Chuang, K., Chang, C.-H., Li, M., Lu, C.-H., Chen, W., Wei, P.-H., Pan, I.-H., et al. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220056 · Cited by 6

The Ups and Downs of BACE1: Walking a Fine Line between Neurocognitive and Other Psychiatric Symptoms of Alzheimer’s Disease

Ovsepian, S. V., Horáček, J., O’Leary, V. B., & Höschl, C. (2020) · The Neuroscientist · doi:10.1177/1073858420940943 · Cited by 8

The UNC5C T835M mutation associated with Alzheimer’s disease leads to neurodegeneration involving oxidative stress and hippocampal atrophy in aged mice

Karunakaran, D. K. P., Ley, M. L., Guo, J., Khatri, A. W., Sadleir, K. R., Popović, J., Upadhyay, A. K., Savas, J. N., Procissi, D., Atwal, J. K., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00850-z · Cited by 5

Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer’s Disease

Saadh, M. J., Muhammad, F. A., Alazzawi, T. S., Fahdil, A. A., Athab, Z. H., Tuxtayev, J., Alsaikhan, F., & Farhood, B. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04833-5 · Cited by 5

Antidiabetic and Neuroprotective Effect of the N‐Butanol Extract of Fragaria nilgerrensis Schlecht. in STZ‐Induced Diabetic Mice

Gao, L., Wang, X., Lin, Z., Song, N., Liu, X., Chi, X., & Shao, T. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/6938370 · Cited by 5

Examination of Longitudinal Alterations in Alzheimer’s Disease-Related Neurogenesis in an APP/PS1 Transgenic Mouse Model, and the Effects of P33, a Putative Neuroprotective Agent Thereon

Szögi, T., Borbély, E., Schuster, I., Bozsó, Z., Sántha, M., Tóth, M. E., Penke, B., & Fülöp, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810364 · Cited by 6

Bilateral Hippocampal Volume Mediated the Relationship Between Plasma BACE1 Concentration and Memory Function in the Early Stage of Alzheimer’s Disease: A Cross-Sectional Study

Yin, W., Wan, K., Zhu, W., Zhou, X., Tang, Y., Zheng, W., Cao, J., Song, Y., Zhao, H., Zhu, X., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221174 · Cited by 5

Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?

Li, J., Huang, L., Liu, F., Tang, B., & Yan, X. (2017) · BMC Neurology · doi:10.1186/s12883-017-0942-y · Cited by 5

Highly efficient gene silencing in mouse brain by overhanging‐duplex oligonucleotides via intraventricular route

Mon, S. S. L., Yoshioka, K., Jia, C., Kunieda, T., Asami, Y., Yoshida‐Tanaka, K., Piao, W., Kuwahara, H., Nishina, K., Nagata, T., et al. (2020) · FEBS Letters · doi:10.1002/1873-3468.13742 · Cited by 5

Seizure-6 proteins highlight BACE1 functions in neurobiology

Pigoni, M., Gunnersen, J. M., & Lichtenthaler, S. F. (2016) · Oncotarget · doi:10.18632/oncotarget.13801 · Cited by 5

Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis

Chen, M., Ning, Y., Yang, H., & Jia, J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05500-5 · Cited by 4

BACE1 : Biological Functions and Involvement in the Pathophysiology of Alzheimer's Disease and Other Neurological Disorders

Bartolić, M., & Bosak, A. (2025) · BioFactors · doi:10.1002/biof.70071 · Cited by 4

Axonal Organelle Buildup from Loss of AP-4 Complex Function Causes Exacerbation of Amyloid Plaque Pathology and Gliosis in Alzheimer's Disease Mouse Model

Orlowski, A., Karippaparambil, J., Paumier, J., Ghanta, S., Pallares, E., Chandran, R., Edmison, D., Tandukar, J., Gao, R., & Gowrishankar, S. (2024) · eNeuro · doi:10.1523/eneuro.0445-24.2024 · Cited by 4

Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG Study

Lopez, S., Percio, C. D., Forloni, G., Frasca, A., Drinkenburg, W. H. I. M., Lizio, R., Noce, G., Ferri, R., Soricelli, A., Stocchi, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239072 · Cited by 4

Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice

Sadleir, K. R., Popovoic, J., Zhu, W., Reidel, C. T., Do, H., Silverman, R. B., & Vassar, R. J. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210713125333 · Cited by 4

Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat

Querol‐Vilaseca, M., Sirisi, S., Molina‐Porcel, L., Molina-Esteve, B., Pegueroles, J., Ferrer‐Raventós, P., Núñez‐Llaves, R., Dols‐Icardo, O., Balasa, M., Iulita, M. F., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12781 · Cited by 4

Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomes

Richter, G., Kirsebom, B., Jarholm, J. A., Pålhaugen, L., Gísladóttir, B., Aarsland, D., Grøntvedt, G. R., Skogseth, R. E., Waterloo, K. K., Fladby, T., et al. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.07.005 · Cited by 3

HDAC6 regulates BACE1 stability and NLRP3 inflammasome activation in Alzheimer's disease

Lee, J., Cho, Y., Choi, B. Y., Kim, H. K., Lee, Y., Kim, E., Han, J., Sul, J. H., Kim, J. S., Baek, S. H., et al. (2026) · Brain · doi:10.1093/brain/awag089 · Cited by 5

Multicolor, Cell-Impermeable, and High Affinity BACE1 Inhibitor Probes Enable Superior Endogenous Staining and Imaging of Single Molecules

Stockinger, F., Poc, P., Möhwald, A., Karch, S., Häfner, S., Alzheimer, C., Sandoz, G., Huth, T., & Broichhagen, J. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00339 · Cited by 4

Association of Neurogranin and BACE1 With Clinical Cognitive Decline in Individuals With Subjective Cognitive Decline

Wang, X., Freiesleben, S. D., Schneider, L., Preis, L., Priller, J., Spruth, E. J., Altenstein, S., Schneider, A., Fließbach, K., Wiltfang, J., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209806 · Cited by 3

β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4396-06.2007 · Cited by 365

β‐Secretase‐1 elevation in aged monkey and Alzheimer’s disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β‐amyloid accumulation

Cai, Y., Xiong, K., Zhang, X., Cai, H., Luo, X., Feng, J., Clough, R. W., Struble, R. G., Patrylo, P. R., Chu, Y., et al. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07376.x · Cited by 62

P1-160 The role of the tissue-type plasminogen activator in the course of amyloid accumulation

Cacquevel, M., Chéenne, S., Castel, H., Bénavidès, J., Pradier, L., & Vivien, D. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(04)80473-1

β‐Secretase‐1 elevation in transgenic mouse models of Alzheimer’s disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development

Zhang, X., Cai, Y., Xiong, K., Cai, H., Luo, X., Feng, J., Clough, R. W., Struble, R. G., Patrylo, P. R., & Yan, X. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07017.x · Cited by 120

Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains

Harada, H., Tamaoka, A., Ishii, K., Shoji, S., Kametaka, S., Kametani, F., Saito, Y., & Murayama, S. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.10.001 · Cited by 62